◀ Back to PTGS2

MSH3 — PTGS2

Text-mined interactions from Literome

Barnett et al., Am J Physiol Gastrointest Liver Physiol 2000 (Gastritis) : Basal acid secretion in both groups of rats was not affected by pretreatment with DuP-697 , a selective inhibitor of cyclooxygenase-2
Caruso et al., Neuroendocrinology 2004 : alpha-MSH and HS024 ( 1 nmol/rat ) alone had no effect on iNOS and COX-2 expression
Wang et al., FASEB J 2005 (MPTP Poisoning) : MPP induced PGE2 increase was completely abolished by treatment with DuP697 , a COX-2 selective inhibitor
Peng et al., Ann Hematol 2008 (Leukemia, Myelogenous, Chronic, BCR-ABL Positive) : Dup-697 , a specific COX-2 inhibitor , suppresses growth and induces apoptosis on K562 leukemia cells by cell-cycle arrest and caspase-8 activation
Kim et al., Anesth Analg 2012 (Disease Models, Animal...) : The effects of intrathecally administered tianeptine and DUP-697 ( a cyclooxygenase-2 inhibitor ) were examined on flinching behavior evoked by intraplantar formalin injection, and their interaction was characterized using isobolographic analysis
Hay et al., Neuroreport 1997 (Hyperalgesia) : However, DuP 697 potentiated COX-2 mRNA induction, which indicates the existence of a potential regulatory mechanism to overcome COX-2 inhibition